NEWS:
- KBIO: a group led by Martin Shkreli has taken a majority position in outstanding shares of the company( Jeez...UP over 700% this morning, wish i had this one)
- AAPL:Apple seeking second supplier for next-generation Apple Watch, reports digitimes
- SUNE: Blackstone’s GSO will not backstop SunEdison debt, reports reuters
- UNH: guides lower: cuts FY15 to $6.00 from $6.25-$6.35
- LLY: MRK: Eli Lilly, Merck expand immuno-oncology collaboration
- LLTP: FDA approves Adapt Pharma’s nasal spray for opioid overdose
- SINA:Sina Finds Success in Alibaba Friendship, reports wsj
- TRP: announces new layoffs
- ATHX: MAPC effective in improving health of animals after acute rodent SCI
- VZ:Verizon gets FCC waiver permitting Wi-Fi calling
THE ECONOMIC CALENDAR:
- 8:30AM: Initial Jobless Claims
- 8:30AM: Philly Fed Business Outlook
- 9:45AM: Bloomberg Consumer Comfort Index
- 10AM: Leading Indicators
- 10:30AM: EIA Natural Gas Inventory
- 4:30PM: Money Supply and Fed Balance Sheet
NOTABLE EARNINGS REPORTED YESTERDAY AFTER THE CLOSE:
- GMCR:FQ4 EPS of $0.85 beats by $0.14: revenue of $1.04B beats by $10M: revenue -13.3% y/y: guides in-line( up 18% thisd morning)
- SINA:Q3 EPS of $0.39 beats by $0.19: revenue of $223.7M beats by $0.94M: revenue +14.1% y/y:
- CRM:FQ3 EPS of $0.21 beats by $0.02: revenue of $1.71B beats by $10M: revenue +23.9$% y/y: strong guidance: guides FY17 revenue $8B-$8.1B vs. consensus $7.99B
- NTAP: FQ2 EPS of $0.61 beats by $0.04: revenue of $1.45B beats by $20M: revenue -5.8% y/y: guides in-line
- CTRP:Q3 EPS of $2.20 may not be comparable to consensus of $0.09: revenue of $501M beats by $10.36M: revenue +49.0% y/y: guides revenue above consensus( up 12% this morning, watch PCLN morning as well)
- WB: Q3 EPS of $0.10 beats by $0.04: revenue of $124.7M beats by $2.9M: revenue +48.2$% y/y: guides in-line
- TUMI:Q3 EPS of $0.22 beats by $0.01: revenue of $131.1M misses by $4.5M: revenue +0.7% y/y
- LB: Q3 EPS of $0.55 beats by $0.03: revenue of $2.49B in-line: revenue +7.3% y/y: guides below consensus
NOTABLE EARNINGS REPORTED TODAY BEFORE THE OPENING:
- SSI:Q3 EPS of -$0.29 misses by $0.10: revenue of $351.58M misses by $8.09M: revenue -3.5% y/y: lowers guidance, cuts FY15 adjusted EPS to 70c-80c from $1.05-$1.15, consensus $1.00
- KIRK:Q3 EPS of -$0.02 misses by $0.06: revenue of $129.24M misses by $2.03M: revenue +10.3% y/y: weak guidance
- JKS:Q3 EPS of $1.04 beats by $0.02: revenue of $637.6M beats by $76.32M: revenue +52.8% y/y
- CATO:Q3 EPS of $0.30 beats by $0.04: revenue of $225.47M in-line: revenue +4.4% y/y
- SPB: FQ4 EPS of $1.13 misses by $0.03: revenue of $1.31B misses by $20M: revenue +11.0% y/y
NOTABLE EARNINGS TO BE REPORTED TODAY AFTER THE CLOSE:
- ADSK, ANW, ASYS, ESL, GPS, INTU, KEYS, MENT, MOMO, NGVC, NMBL, ROST, SPLK, TFM, WAIR, WDAY, WSM, ZOES
ANALYSTS’ RATINGS CHANGES:
UPGRADES:
- NGG: upgrade; sector perform to outperform: RBC Capital
- GD: upgrade: hold to buy: Argus:
- SUN: upgrade: perform to outperform: Credit Suisse
- WEN: upgrade: neutral to conviction buy: Goldman (that’s a double upgrade)
DOWNGRADES:
- BOOT: downgrade: outperform to market perform: Wells Fargo
- BLMN: downgrade: conviction buy to buy: Goldman: pt cut from $24 to $22
- EAT: downgrade; buy to neutral: Goldman
- LONG: downgrade: buy to hold: Brean Capital
- TWI: downgrade: neutral to sell: Goldman: pt cut from $8 to $3
INITIATIONS:
- ORMP: initiated: outperform: FBR Capital: $15
- AST: initiated: outperform: FBR Capital: $10
PRICE TARGET CHANGES:
- CTRP: pt raised from $115 to $125: Piper Jaffray
- CTRP: pt raised from $96 to $130: Brean Capital
- CTRP: pt raised from $100 to $130: Oppenheimer
- PRTA: pt raised from $75 to $95: RBC Capital
- CRM: pt raised from $85 to $93: Wunderlich
- CRM: pt raised from $85 to $95: Northland Capital
- CRM: pt raised from $80 to $90: Mizuho
- LOW: pt raised from $81 to $83: RBC Capital
- CA: pt raised from $30 to $31: RBC Capital
- LGND: pt raised from $138 to $144: Roth Capital
- DIS: pt cut from $136 to $133: Topeka Capital
- GMRC: pt cut from $58 to $50: Roth Capital
- GES: pt cut from $21 to $17: Pivotal Research
- WYNN: pt cut from $69 to $68: Telsey Advisory Group
- VIPS: pt cut from $265 to $17: Brean Capital (This is stupid , VIPS had 10:1 spit, they shoud do from 26.5 to 17)